Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.280
-0.090 (-2.67%)
At close: Jun 27, 2025, 4:00 PM
3.260
-0.020 (-0.61%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $19.32 million as of June 27, 2025. Its market cap has increased by 196.32% in one year.
Market Cap
19.32M
Enterprise Value
18.37M
1-Year Change
196.32%
Ranking
Category
Stock Price
$3.28
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $19.32M, a decrease of -81.34%. That is a compound annual growth rate of -31.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 14.61M | -42.19% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |